In contrast incubation of our lead compound with hiPSC-CMs derived from a patient with a sodium channel defect causing LQT3 (Nav1.5-N406K)40, results in significant shortening of the APD and correction of the abnormal phenotype (Fig. 8B,C). Here, SCN5A is linked to long QT syndrome 3.